Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:6826365rdf:typepubmed:Citationlld:pubmed
pubmed-article:6826365lifeskim:mentionsumls-concept:C0021494lld:lifeskim
pubmed-article:6826365lifeskim:mentionsumls-concept:C0020155lld:lifeskim
pubmed-article:6826365lifeskim:mentionsumls-concept:C0004048lld:lifeskim
pubmed-article:6826365lifeskim:mentionsumls-concept:C0333117lld:lifeskim
pubmed-article:6826365pubmed:issue1lld:pubmed
pubmed-article:6826365pubmed:dateCreated1983-4-7lld:pubmed
pubmed-article:6826365pubmed:abstractTextThis study in human volunteers was designed to compare the retention of diethylenetriaminepentaacetic acid (DTPA) in the body after intravenous (i.v.) injection with that following inhalation by using a 14C labelled tracer. After i.v. injection retention in the blood could be described by three exponential components with half-times of about 1.4 min (approximately 60%) 14.3 min (approximately 20%) and 95 min (approximately 20%). By 24 hr more than 99% of the 14C-DTPA had been excreted in the urine and less than 0.5% remained in the plasma. After inhalation of 14C-DTPA retention in the lungs could be represented by a single component with a half time of about 75 min. As a consequence the length of time that a therapeutically useful amount of DTPA is retained in the body is approximately twice that following intravenous injection.lld:pubmed
pubmed-article:6826365pubmed:languageenglld:pubmed
pubmed-article:6826365pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6826365pubmed:citationSubsetIMlld:pubmed
pubmed-article:6826365pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6826365pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6826365pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:6826365pubmed:statusMEDLINElld:pubmed
pubmed-article:6826365pubmed:monthJanlld:pubmed
pubmed-article:6826365pubmed:issn0017-9078lld:pubmed
pubmed-article:6826365pubmed:authorpubmed-author:SmithHHlld:pubmed
pubmed-article:6826365pubmed:authorpubmed-author:BaileyM RMRlld:pubmed
pubmed-article:6826365pubmed:authorpubmed-author:BulmanR ARAlld:pubmed
pubmed-article:6826365pubmed:authorpubmed-author:CrawleyF EFElld:pubmed
pubmed-article:6826365pubmed:authorpubmed-author:StatherJ WJWlld:pubmed
pubmed-article:6826365pubmed:authorpubmed-author:BirchallAAlld:pubmed
pubmed-article:6826365pubmed:issnTypePrintlld:pubmed
pubmed-article:6826365pubmed:volume44lld:pubmed
pubmed-article:6826365pubmed:ownerNLMlld:pubmed
pubmed-article:6826365pubmed:authorsCompleteYlld:pubmed
pubmed-article:6826365pubmed:pagination45-52lld:pubmed
pubmed-article:6826365pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:6826365pubmed:meshHeadingpubmed-meshheading:6826365-...lld:pubmed
pubmed-article:6826365pubmed:meshHeadingpubmed-meshheading:6826365-...lld:pubmed
pubmed-article:6826365pubmed:meshHeadingpubmed-meshheading:6826365-...lld:pubmed
pubmed-article:6826365pubmed:meshHeadingpubmed-meshheading:6826365-...lld:pubmed
pubmed-article:6826365pubmed:meshHeadingpubmed-meshheading:6826365-...lld:pubmed
pubmed-article:6826365pubmed:meshHeadingpubmed-meshheading:6826365-...lld:pubmed
pubmed-article:6826365pubmed:meshHeadingpubmed-meshheading:6826365-...lld:pubmed
pubmed-article:6826365pubmed:meshHeadingpubmed-meshheading:6826365-...lld:pubmed
pubmed-article:6826365pubmed:meshHeadingpubmed-meshheading:6826365-...lld:pubmed
pubmed-article:6826365pubmed:year1983lld:pubmed
pubmed-article:6826365pubmed:articleTitleThe retention of 14C-DTPA in human volunteers after inhalation or intravenous injection.lld:pubmed
pubmed-article:6826365pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:6826365pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:6826365pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:6826365lld:pubmed